Central Nervous System News and Research

RSS

SLU researcher receives $608,376 grant to design better clinical treatments for multiple sclerosis

Saint Louis University researcher Daniel Hawiger, M.D., Ph.D., has been awarded $608,376 from the National Multiple Sclerosis Society to gain a better understanding of how the autoimmune process that causes multiple sclerosis (MS) may be stopped or slowed down.

9 Apr 2014

Researchers identify potential treatment targets for incurable form of pediatric brain cancer

Researchers from the University of Toronto's Department of Laboratory Medicine and Pathobiology (LMP) have defined potential treatment targets for a previously incurable form of pediatric brain cancer called Diffuse Intrinsic Pontine Glioma (DIPG).

8 Apr 2014

President of Ukrainian Osteoporosis Association wins CNS Medal for contribution to cause of osteoporosis prevention

Today, Dr Vladyslav Povoroznyuk, President of the Ukrainian Osteoporosis Association, was awarded the first Committee of National Societies (CNS) Medal. The CNS Medal recognizes an individual CNS representative who has made an important contribution to the cause of osteoporosis prevention through active participation in CNS activities and by expanding IOF's messages and outreach in his/her country.

7 Apr 2014

Expert in gene therapy joins The Children's Hospital of Philadelphia

Beverly L. Davidson, Ph.D., a nationally prominent expert in gene therapy, is joining The Children's Hospital of Philadelphia (CHOP) today.

2 Apr 2014

Oats Nutrition and Technology: A comprehensive textbook from Quaker

Considered the most comprehensive and up-to-date textbook about the life cycle of oats, Oats Nutrition and Technology was released from Wiley-Blackwell publishers, and is now available at all major online publishing websites, including Amazon.com.

2 Apr 2014

Uric acid in urine generates potentially hazardous in swimming pools by interacting with chlorine

A new study shows how uric acid in urine generates potentially hazardous "volatile disinfection byproducts" in swimming pools by interacting with chlorine, and researchers are advising swimmers to observe "improved hygiene habits.

2 Apr 2014

Actavis announces acquisition of Silom Medical for $100 million

Actavis plc, a leading global specialty pharmaceutical company today announced that it has acquired Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand, for approximately $100 million in cash.

1 Apr 2014

Researchers identify possible mechanism for re-growing damaged nerve fibres in central nervous system

A new discovery suggests it could one day be possible to chemically reprogram and repair damaged nerves after spinal cord injury or brain trauma.

1 Apr 2014

Early rehabilitation improves neurofunctional outcome after surgery in children with spinal tumors

In children, primary spinal tumors comprise 4% of all tumors from the central nervous system. Spinal tumors can present with a variety of clinical signs and symptoms in children such as pain followed by motor regression, gait disturbance, sphincter dysfunction, sensory symptoms, torticollis, and kyphoscoliosis.

1 Apr 2014

Researchers develop fluorescent sensor to identify presence of drug used to spike beverages

A team of researchers from the National University of Singapore (NUS) has developed the world's first fluorescent sensor to identify the presence of a drug known as GHB that is commonly used to spike beverages. When the sensor is mixed with a sample of a beverage containing GHB, the mixture changes colour in less than 30 seconds, making detection of the drug fast and easy.

29 Mar 2014

Researchers develop potentially safer and more cost-effective therapeutics against West Nile virus

An international research group led by Arizona State University professor Qiang "Shawn" Chen has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus and other pathogens.

29 Mar 2014

Novartis’ investigational compound achieves overall response rate of 58% in patients with ALK+ NSCLC

Novartis today announced that The New England Journal of Medicine (NEJM) published clinical trial results showing the investigational compound LDK378 (ceritinib) achieved an overall response rate (ORR, including complete response [CR] and partial response [PR]) of 58% and a median progression-free survival (PFS) of seven months in adults with advanced anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC) who received 400 mg or higher of LDK378 per day.

28 Mar 2014

Researchers develop fluorescent sensor to identify presence of drug in less than 30 seconds

27 Mar 2014

SAGE Therapeutics doses first patient in SAGE-547 Phase 1/2 trial for treatment of SRSE

SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening and rare central nervous system (CNS) disorders, today announced dose initiation of the first patient in a Phase 1/2 clinical trial of SAGE-547, a neuroactive steroid, in super-refractory status epilepticus (SRSE), a critical condition in which the brain is in a state of persistent seizure.

27 Mar 2014

Scientists discover role of protons in neurotransmission

While probing how organisms sense gravity and acceleration, scientists at the Marine Biological Laboratory (MBL) and the University of Utah uncovered evidence that acid (proton concentration) plays a key role in communication between neurons.

27 Mar 2014

Research may lead the way toward new treatments for proliferative retinopathies

A new report published online in The FASEB Journal may lead the way toward new treatments or a cure for a common cause of blindness (proliferative retinopathies). Specifically, scientists have discovered that the body's innate immune system does more than help ward off external pathogens.

27 Mar 2014

Study points to potential culprit that kills motor neurons in ALS

Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, is marked by a cascade of cellular and inflammatory events that weakens and kills vital motor neurons in the brain and spinal cord. The process is complex, involving cells that ordinarily protect the neurons from harm. Now, a new study by scientists in The Research Institute at Nationwide Children's Hospital points to a potential culprit in this good-cell-gone-bad scenario, a key step toward the ultimate goal of developing a treatment.

27 Mar 2014

Treatment with natalizumab in patients with MS appears linked with JC virus infection

Treatment with natalizumab in patients with multiple sclerosis (MS) appears linked with JC virus (JCV) infection, which can lead to a rare and often fatal demyelinating disease of the central nervous system called progressive multifocal leukoencephalopathy (PML) that destroys the myelin that protects nerve cells.

25 Mar 2014

China Pharma Holdings' revenue decreases 40% to $32.8 million in fiscal year 2013

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the year ended December 31, 2013.

21 Mar 2014

Eye abnormalities may help reveal features of early-stage Alzheimer's disease, says study

Investigators at the Cedars-Sinai Regenerative Medicine Institute have discovered eye abnormalities that may help reveal features of early-stage Alzheimer's disease. Using a novel laboratory rat model of Alzheimer's disease and high-resolution imaging techniques, researchers correlated variations of the eye structure, to identify initial indicators of the disease.

18 Mar 2014

Central Nervous System News and Research

SLU researcher receives $608,376 grant to design better clinical treatments for multiple sclerosis

Researchers identify potential treatment targets for incurable form of pediatric brain cancer

President of Ukrainian Osteoporosis Association wins CNS Medal for contribution to cause of osteoporosis prevention

Expert in gene therapy joins The Children's Hospital of Philadelphia

Oats Nutrition and Technology: A comprehensive textbook from Quaker

Uric acid in urine generates potentially hazardous in swimming pools by interacting with chlorine

Actavis announces acquisition of Silom Medical for $100 million

Researchers identify possible mechanism for re-growing damaged nerve fibres in central nervous system

Early rehabilitation improves neurofunctional outcome after surgery in children with spinal tumors

Researchers develop fluorescent sensor to identify presence of drug used to spike beverages

Researchers develop potentially safer and more cost-effective therapeutics against West Nile virus

Novartis’ investigational compound achieves overall response rate of 58% in patients with ALK+ NSCLC

Researchers develop fluorescent sensor to identify presence of drug in less than 30 seconds

SAGE Therapeutics doses first patient in SAGE-547 Phase 1/2 trial for treatment of SRSE

Scientists discover role of protons in neurotransmission

Research may lead the way toward new treatments for proliferative retinopathies

Study points to potential culprit that kills motor neurons in ALS

Treatment with natalizumab in patients with MS appears linked with JC virus infection

China Pharma Holdings' revenue decreases 40% to $32.8 million in fiscal year 2013

Eye abnormalities may help reveal features of early-stage Alzheimer's disease, says study

Event guide: The 7th CNS Drug Delivery Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News